[Mono- or polytherapy of epilepsy?]

Area of Science:

• Neurology
• Pharmacology

Context:

• Epilepsy treatment traditionally relies on anticonvulsant polytherapy.
• Evidence supporting polytherapy's superiority over monotherapy is limited.
• Polytherapy presents challenges including chronic toxicity and drug interactions.

Purpose:

• To evaluate the efficacy and risks of anticonvulsant polytherapy versus monotherapy in epilepsy.
• To explore the potential for monotherapy in new epilepsy referrals.
• To assess the feasibility and impact of reducing polytherapy in chronic patients.

Summary:

• Anticonvulsant polytherapy, while common, shows minimal advantages over monotherapy and introduces risks like toxicity and seizure exacerbation.
• New epilepsy patients demonstrate significant potential for successful monotherapy.
• Reducing polytherapy in chronic patients may decrease toxicity and improve seizure control, but carries risks of withdrawal seizures.

Impact:

• Highlights the limited evidence for polytherapy's benefits in epilepsy management.
• Suggests a shift towards prioritizing monotherapy and careful polytherapy reduction.
• Emphasizes the need for improved monitoring and rationalization of anticonvulsant therapy to minimize complications.